PPD Global

PPD, now a part of Thermo Fisher Scientific, is a leading global contract research organization (CRO) providing comprehensive, integrated drug development, laboratory, and lifecycle management services. The company supports pharmaceutical, biotechnology, medical device, academic, and government organizations through all phases of clinical development, from preclinical to post-approval. PPD's expertise spans a wide range of therapeutic areas, including oncology, infectious diseases, and cardiovascular health. Following its acquisition by Thermo Fisher Scientific in 2021, PPD operates as part of the Clinical Research Services business. The company is recognized for its robust clinical trial management, advanced laboratory services, and data-driven approach to drug development. PPD's global reach and deep scientific expertise help clients accelerate the delivery of safe and effective therapeutics to patients.